Heart Health
Bempedoic Acid Cuts Venous Clot Risk by 42% in Statin-Intolerant Patients
A post hoc analysis of the CLEAR Outcomes trial finds bempedoic acid significantly reduces DVT and pulmonary embolism risk.
Artigo Científico
29 de mai. de 2026 0
Resultados para "Bempedoic Acid"
20 artigos
Longevity & Aging
Ácido Bempedoico Considerado Seguro o Suficiente para Permitir a Continuação da Amamentação
Nova orientação sugere que mães em uso de ácido bempedoico para controle do colesterol não precisam interromper a amamentação, embora seja recomendada cautela no caso de recém-nascidos.
Artigo Científico
7 de jun. de 2026 0
Heart Health
Combinação de Ácido Bempedoico e Ezetimibe Tem como Alvo o LDL em Pacientes Diabéticos
Um ensaio clínico de Fase 2 testa se um comprimido de combinação em dose fixa pode reduzir com segurança o LDL colesterol em pessoas com diabetes tipo 2.
Ensaio Clínico
17 de jun. de 2026 0
Metabolic Health
Cholesterol Drug Bempedoic Acid Activates Key Fat-Burning Pathway in Liver Cells
New research reveals how the cholesterol medication bempedoic acid directly activates PPARα, boosting fat metabolism beyond its known effects.
Artigo Científico
29 de mar. de 2026 3
Longevity & Aging
BHB Supplement Shields Brain from Damage Caused by Saturated Fat Diets
Beta-hydroxybutyrate restores AMPA receptor function and prevents memory loss triggered by saturated fat-rich diets in mice.
Artigo Científico
31 de mai. de 2026 0
Brain Health
Molécula de Ácido Graxo Erucamida Interrompe a Degeneração Retiniana em Camundongos
Um ácido graxo amida de ocorrência natural ativa células imunes na retina, protegendo neurônios e vasos sanguíneos de danos degenerativos.
Artigo Científico
21 de jun. de 2026 0
Brain Health
BACE Inhibitor Atabecestat Trial in Pre-Symptomatic Alzheimer's Risk Terminated Early
A phase 2/3 trial of the BACE inhibitor atabecestat in amyloid-positive asymptomatic adults was terminated before completion, raising questions about this drug class.
Ensaio Clínico
13 de mai. de 2026 0
Longevity & Aging
FDA Approves First-in-Class Blood Pressure Pill That Targets Aldosterone at the Source
Baxdrostat blocks aldosterone production directly, cutting systolic BP by ~15 mmHg in resistant hypertension patients who failed other drugs.
Comunicado de Imprensa
19 de mai. de 2026 0
Metabolic Health
FDA Approves Baxfendy, a New Aldosterone Synthase Inhibitor for Hypertension
Baxdrostat becomes the first-in-class aldosterone synthase inhibitor approved to treat resistant hypertension alongside existing drugs.
Aprovação de Medicamento
19 de mai. de 2026 0
Longevity & Aging
Composto Vegetal Epiberberina Controla a Inflamação Intestinal ao Corrigir a Reciclagem de Ácidos Biliares
Um alcaloide natural da medicina tradicional chinesa ativa um receptor-chave de ácidos biliares para restaurar o equilíbrio intestinal e reduzir a inflamação da colite.
Artigo Científico
4 de jun. de 2026 0
Longevity & Aging
BPC 157 Peptide Controls Angiogenesis and Nitric Oxide for Broad Healing Benefits
A comprehensive review argues that BPC 157's effects on angiogenesis and nitric oxide are therapeutic assets, not risks, with anti-tumor and neuroprotective evidence.
Artigo Científico
31 de mai. de 2026 0
Brain Health
Herbal Compound Clears Alzheimer's Plaques by Activating AMPK Autophagy Pathway
A traditional Chinese herbal formula improves cognition and cerebrovascular health in Alzheimer's mice by activating the LKB1-AMPK-SIRT1 autophagy cascade.
Artigo Científico
21 de mai. de 2026 0
Longevity & Aging
BPC 157 Defends Against Cancer and Neurodegeneration by Mastering Angiogenesis and Nitric Oxide
Researchers rebut claims that BPC 157 promotes tumor growth or neurodegeneration, citing evidence it modulates—not dysregulates—angiogenesis and NO.
Artigo Científico
18 de mai. de 2026 0
Longevity & Aging
FDA Approves First Aldosterone Synthase Inhibitor BAXFENDY to Tackle Resistant Hypertension
AstraZeneca's BAXFENDY cuts systolic blood pressure by nearly 10 mmHg beyond placebo in adults whose BP wasn't controlled by other drugs.
Comunicado de Imprensa
20 de mai. de 2026 0
Longevity & Aging
Methylene Blue Cuts Postoperative Delirium by Calming Brain Inflammation
FDA-approved methylene blue reduced delirium-like behavior in surgical mice by suppressing neuroinflammation and repairing the blood-brain barrier.
Artigo Científico
18 de mai. de 2026 0
Longevity & Aging
A Berberina Protege o Fígado ao Mesmo Tempo que Potencializa o Poder da Evodiamina no Combate à Colite
Combinar dois compostos herbais tradicionais resolve um perigoso problema de toxicidade hepática e torna o tratamento da colite significativamente mais eficaz.
Artigo Científico
6 de jun. de 2026 0
Longevity & Aging
NACET Compound Activates Cellular Defense Against Age-Related Eye Disease
Modified antioxidant shows promise for preventing diabetic retinopathy and macular degeneration by boosting cellular protection.
Artigo Científico
19 de abr. de 2026 0
Brain Health
New Alzheimer's Drug BMS-984923 Completes Safety Testing in 51 Participants
Phase 1b trial tests escalating doses of experimental Alzheimer's treatment BMS-984923 for safety and tolerability in older adults.
Ensaio Clínico
28 de mar. de 2026 1
Longevity & Aging
Methylene Blue Emerges as a Versatile Clinical Tool Beyond Emergency Medicine
A comprehensive review reveals methylene blue's expanding role from toxicology emergencies to perioperative care, neurology, and oncology.
Artigo Científico
13 de mai. de 2026 0
Brain Health
Retired Cholesterol Drug Shows Promise for Alzheimer's Prevention in Small Trial
Probucol, a discontinued cholesterol medication, may boost brain-protective proteins in older adults at risk for dementia.
Ensaio Clínico
29 de mar. de 2026 0
Página 1 de 2Próximo